Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3365 results

Sort By:

Integrating MOUD in African American Community Settings (Better Together)

Study ID: NCT06416020
Start Date: 2025-05-19
End Date: 2028-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

330

Intervention / Treatment

HC-fashion only

Bt-fashion withh buprerenorphine

Sponsor

Howard University

Source: clinicaltrials.gov

Share:
Add to list

Technology-supported Interventions for Prolonged Grief Disorder (PGD)

Study ID: NCT06932120
Start Date: 2025-09-08
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

141

Intervention / Treatment

Internet-based treatment (GROw) combined with face-to-face videoconferencing sessions with a therapist in BF-GROw group

Internet-based treatment (GROw) supported by the App developed which contains the EMA and EMI tools in iGROw group.

Sponsor

Jaume I University

Source: clinicaltrials.gov

Share:
Add to list

Machine Learning and 3D Image-Based Modeling for Real-Time Body Weight and Body Composition Estimation During Emergency Medical Care. Study 1

Study ID: NCT06646120
Start Date: 2025-07-01
End Date: 2026-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment
Sponsor

Florida Atlantic University

Source: clinicaltrials.gov

Share:
Add to list

Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer

Study ID: NCT06952920
Start Date: 2025-08-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

388

Intervention / Treatment

electrocutufuncture

standard quadruple antiemetic therapy

sham electroacupuncture

standard quadruple antiemetic therapy

Sponsor

J IU fight Zhao

Source: clinicaltrials.gov

Share:
Add to list

A Study to Investigate the Efficacy and Safety Profile of GM-XANTHO [GM-XAN003] in Patients with Psoriasis

Study ID: NCT06620692
Start Date: 2025-10-01
End Date: 2028-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

65

Intervention / Treatment

5% GM-Xanthos [GM-XAN003]

Placebo

Sponsor

Xantho Biotechnology Co., LTD

Source: clinicaltrials.gov

Share:
Add to list

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

Study ID: NCT06901492
Start Date: 2025-06-01
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Prostate biopsy guided by PSMA PET/CT

Prostate biopsy guided by mpMRI/US

Systematic prostate biopsy

Sponsor

Nanjing First Hospital, Nanjing Medical University

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Study ID: NCT06817720
Start Date: 2025-07-30
End Date: 2027-03-07
Study Type

Interventional

Study Phase

Phase2

No. of Participants

50

Intervention / Treatment

fluffy

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene

Study ID: NCT06817694
Start Date: 2025-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Cognitive-behavioral group therapy

Sponsor

Quebec-University Laval Chu

Source: clinicaltrials.gov

Share:
Add to list

Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Drinking

Study ID: NCT06670794
Start Date: 2026-01-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Web-based intervention for concerned partners

Psychoeducation control

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Study ID: NCT06922591
Start Date: 2025-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

133

Intervention / Treatment

TNG462

RMC-9805

RMC-6236

Sponsor

Tango Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list